NasdaqCM:AMEH

Stock Analysis Report

Executive Summary

Apollo Medical Holdings, Inc., a physician-centric integrated population health management company, provides medical care services.

Snowflake

Fundamentals

High growth potential with adequate balance sheet.


Similar Companies

Share Price & News

How has Apollo Medical Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-1.8%

AMEH

4.6%

US Healthcare

2.3%

US Market


1 Year Return

-16.1%

AMEH

-8.5%

US Healthcare

5.6%

US Market

Return vs Industry: AMEH underperformed the US Healthcare industry which returned -8.5% over the past year.

Return vs Market: AMEH underperformed the US Market which returned 5.6% over the past year.


Shareholder returns

AMEHIndustryMarket
7 Day-1.8%4.6%2.3%
30 Day-27.2%-0.1%-1.0%
90 Day-1.3%-4.5%-0.7%
1 Year-16.1%-16.1%-7.1%-8.5%7.9%5.6%
3 Yearn/a31.9%26.5%45.6%36.3%
5 Yearn/a63.7%53.9%65.8%47.6%

Price Volatility Vs. Market

How volatile is Apollo Medical Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Apollo Medical Holdings undervalued compared to its fair value and its price relative to the market?

52.87x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Undervalued: Insufficient data to calculate AMEH's fair value to establish if it is undervalued.

Significantly Undervalued: Insufficient data to calculate AMEH's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: AMEH is poor value based on its PE Ratio (52.9x) compared to the Healthcare industry average (20.3x).

PE vs Market: AMEH is poor value based on its PE Ratio (52.9x) compared to the US market (17.7x).


Price to Earnings Growth Ratio

Low PEG Ratio: AMEH is good value based on its PEG Ratio (0.5x)


Price to Book Ratio

PB vs Industry: AMEH is overvalued based on its PB Ratio (2.8x) compared to the US Healthcare industry average (2.5x).


Next Steps

Future Growth

How is Apollo Medical Holdings forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

112.0%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: AMEH's forecast earnings growth (112% per year) is above the savings rate (2.7%).

Earnings vs Market: AMEH's earnings (112% per year) are forecast to grow faster than the US market (14.5% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: AMEH's revenue (20.3% per year) is forecast to grow faster than the US market (7.3% per year).

High Growth Revenue: AMEH's revenue (20.3% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

High Future ROE: Insufficient data to determine if AMEH's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Apollo Medical Holdings performed over the past 5 years?

18.5%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: AMEH's earnings have grown by 18.5% per year over the past 5 years.

Accelerating Growth: AMEH's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: AMEH had negative earnings growth (-60.1%) over the past year, making it difficult to compare to the Healthcare industry average (5.3%).


Return on Equity

High ROE: AMEH's Return on Equity (11.1%) is considered low.


Return on Assets

ROA vs Industry: AMEH's Return on Assets is below or equal to the Healthcare industry average last year.


Return on Capital Employed

ROCE Improving: AMEH has significantly improved its Return on Capital Employed over the past 3 years.


Next Steps

Financial Health

How is Apollo Medical Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: AMEH's short term assets ($167.6M) exceeds its short term liabilities ($78.3M)

Long Term Liabilities: AMEH's short term assets (167.6M) exceeds its long term liabilities (84.3M)


Debt to Equity History and Analysis

Debt Level: AMEH's debt to equity ratio (11%) is considered satisfactory

Reducing Debt: Insufficient data to determine if AMEH's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: AMEH's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: AMEH earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet

Inventory Level: AMEH has a low level of unsold assets or inventory.

Debt Coverage by Assets: AMEH's debt is covered by short term assets (assets are 3.758420x debt).


Next Steps

Dividend

What is Apollo Medical Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.5%markettop25%3.8%industryaverage1.6%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate AMEH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate AMEH's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if AMEH's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if AMEH's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of AMEH's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of Apollo Medical Holdings's salary, the management and board of directors tenure and is there insider trading?

0.08yrs

Average management tenure


CEO

Kenneth Sim 0

0.08yrs

Tenure

0

Dr. Kenneth T. Sim, M.D., serves as Co-Chief Executive Officer at Apollo Medical Holdings, Inc. since September 30, 2019. Dr. Simhas been an Executive Chairman of Apollo Medical Holdings, Inc. since Decemb ...


Management Age and Tenure

0.08yrs

Average Tenure

Experienced Management: AMEH's management team is not considered experienced ( 0.1 years average tenure), which suggests a new team.


Board Age and Tenure

1.8yrs

Average Tenure

70.5yo

Average Age

Experienced Board: AMEH's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.


Insider Trading

Insider Buying: AMEH insiders have sold more shares than they have bought in the past 3 months.


Recent Insider Transactions

SellUS$1,697,75317 Sep 19
Adrian Vazquez
EntityIndividual
Role
Senior Key Executive
Chief Medical Officer
Shares84,800
Max PriceUS$20.14
BuyUS$40,56017 Sep 19
Michael Eng
EntityIndividual
Role
Member of the Board of Directors
Director
Shares2,000
Max PriceUS$20.28
BuyUS$75,05020 Aug 19
Albert Young WaiChow
EntityIndividual
Role
Chief Administrative Officer
Chief Administrative Officer
Shares5,000
Max PriceUS$15.01
BuyUS$280,74020 Aug 19
Thomas Lam
EntityIndividual
Role
Member of the Board of Directors
President
Shares17,200
Max PriceUS$16.85
BuyUS$15,97020 Aug 19
Michael Eng
EntityIndividual
Role
Member of the Board of Directors
Director
Shares1,000
Max PriceUS$15.97
BuyUS$96,06020 Aug 19
Kenneth Sim
EntityIndividual
Role
Co-Chief Executive Officer
Executive Chairman & Co-Chief Executive Officer
Shares6,000
Max PriceUS$16.35
BuyUS$110,49619 Jun 19
Lakhi Sakhrani
EntityIndividual
Shares7,521
Max PriceUS$14.70
BuyUS$1,63118 Jun 19
John Chiang
EntityIndividual
Role
Member of the Board of Directors
Director
Shares100
Max PriceUS$16.31
BuyUS$30,02914 Jun 19
Eric Chin
EntityIndividual
Role
Chief Financial Officer
CFO & Corporate Secretary
Shares2,040
Max PriceUS$14.72
BuyUS$141,30013 Jun 19
Mark Fawcett
EntityIndividual
Role
Member of the Board of Directors
Director
Shares10,000
Max PriceUS$14.13
BuyUS$101,01613 Jun 19
Thomas Lam
EntityIndividual
Role
Member of the Board of Directors
President
Shares6,900
Max PriceUS$14.64
BuyUS$101,43413 Jun 19
Kenneth Sim
EntityIndividual
Role
Co-Chief Executive Officer
Executive Chairman & Co-Chief Executive Officer
Shares6,996
Max PriceUS$14.51
SellUS$1,390,17005 Jun 19
Adrian Vazquez
EntityIndividual
Role
Senior Key Executive
Chief Medical Officer
Shares85,000
Max PriceUS$16.64
SellUS$581,00001 Dec 18
Warren Hosseinion
EntityIndividual
Shares35,000
Max PriceUS$16.60
SellUS$877,50029 Nov 18
Warren Hosseinion
EntityIndividual
Shares50,000
Max PriceUS$17.91
SellUS$827,70027 Nov 18
Warren Hosseinion
EntityIndividual
Shares50,000
Max PriceUS$17.07
SellUS$731,00022 Nov 18
Warren Hosseinion
EntityIndividual
Shares40,000
Max PriceUS$18.97
SellUS$3,889,74921 Nov 18
Adrian Vazquez
EntityIndividual
Role
Senior Key Executive
Chief Medical Officer
Shares221,597
Max PriceUS$18.56

Ownership Breakdown


Management Team

  • Adrian Vazquez (49yo)

    Chief Medical Officer

    • Tenure: 0yrs
  • Thomas Lam (70yo)

    President

    • Tenure: 1.8yrs
  • Eric Chin

    CFO & Corporate Secretary

    • Tenure: 1.3yrs
  • Kenneth Sim

    Executive Chairman & Co-Chief Executive Officer

    • Tenure: 0.08yrs
  • Hing Ang

    Chief Operating Officer

    • Tenure: 1.8yrs
  • Albert Young WaiChow

    Chief Administrative Officer

    • Tenure: 0.08yrs
  • Brandon Sim

    Interim Chief Technology Officer

    • Tenure: 0.08yrs

Board Members

  • Ernest Bates (82yo)

    Director

    • Tenure: 1.3yrs
  • Dave Schmidt (71yo)

    Director

    • Tenure: 1.8yrs
  • Mark Fawcett (52yo)

    Director

    • Tenure: 0yrs
  • John Chiang

    Director

    • Tenure: 0.8yrs
  • Thomas Lam (70yo)

    President

    • Tenure: 1.8yrs
  • Kenneth Sim

    Executive Chairman & Co-Chief Executive Officer

    • Tenure: 0.08yrs
  • Li Yu

    Director

    • Tenure: 1.8yrs
  • Mitchell Kitayama

    Director

    • Tenure: 1.8yrs
  • Michael Eng

    Director

    • Tenure: 1.8yrs
  • Linda Marsh

    Director

    • Tenure: 0.8yrs

Company Information

Apollo Medical Holdings, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Apollo Medical Holdings, Inc.
  • Ticker: AMEH
  • Exchange: NasdaqCM
  • Founded: 1994
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: US$770.339m
  • Shares outstanding: 50.91m
  • Website: https://www.apollomed.net

Number of Employees


Location

  • Apollo Medical Holdings, Inc.
  • 1668 South Garfield Avenue
  • 2nd Floor
  • Alhambra
  • California
  • 91801
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
AMEHNasdaqCM (Nasdaq Capital Market)YesCommon Stock USUSDDec 2017

Biography

Apollo Medical Holdings, Inc., a physician-centric integrated population health management company, provides medical care services. The company offers care coordination services to principal constituents o ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/17 00:40
End of Day Share Price2019/10/16 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.